Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AECOMACM · Entity 3602 | Director | March 06, 2020 | March 10, 2020 |
| Accolade, Inc.ACCD · Entity 80959 | Director | June 16, 2021 | June 21, 2021 |
| Mirion Technologies, Inc.GSAH · Entity 394 | Director | August 13, 2020 | August 15, 2020 |
| SmileDirectClub, Inc.SDC · Entity 111962 | Director | May 12, 2021 | May 14, 2021 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | May 26, 2022 | May 31, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AECOM
Report date March 06, 2020 · Filed March 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,603 |
Reported balance
After 2020-03-06 transaction · row 1
1 source rowRow 1 · 2020-03-06 · Exercise / conversion · Acquired 5,245 · Balance 51,603 F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-03-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-06 · Exercise / conversion · Disposed 5,245 · Balance 0 F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock.
Accolade, Inc.
Report date June 16, 2021 · Filed June 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 302,895 |
Ending reported balance
After 2021-06-16 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-06-16 · Exercise / conversion · Acquired 250 · Balance 302,229 Row 2 · 2021-06-16 · Exercise / conversion · Acquired 250 · Balance 302,479 Row 3 · 2021-06-16 · Exercise / conversion · Acquired 416 · Balance 302,895 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.50 · Expires 2027-07-26 | Direct | 500 |
Reported balance
After 2021-06-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-06-16 · Exercise / conversion · Disposed 250 · Balance 500 F1: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.70 · Expires 2028-05-02 | Direct | 2,750 |
Reported balance
After 2021-06-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-06-16 · Exercise / conversion · Disposed 250 · Balance 2,750 F2: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.70 · Expires 2028-07-25 | Direct | 5,834 |
Reported balance
After 2021-06-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-06-16 · Exercise / conversion · Disposed 416 · Balance 5,834 F3: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date.
F2: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date.
F3: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date.
Mirion Technologies, Inc.
Report date August 13, 2020 · Filed August 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Sponsor LLC InterestSEC Table II · derivative / convertible security | Direct | 35,000 |
Reported balance
After 2020-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-08-13 · Other · Acquired 35,000 · Balance 35,000 F1: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor
SmileDirectClub, Inc.
Report date May 12, 2021 · Filed May 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,241 |
Reported balance
After 2021-05-12 transaction · row 1
1 source rowRow 1 · 2021-05-12 · Purchase · Acquired 13,000 · Balance 64,241 |
Teladoc Health, Inc.
Report date May 26, 2022 · Filed May 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,726 |
Reported balance
After 2022-05-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-26 · Grant · Acquired 6,726 · Balance 6,726 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SELECT MEDICAL HOLDINGS CORP
Report date June 30, 2026 · Filed July 01, 2026
Section 16 reporting ended · disclosed 2026-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Disposition to issuer · Disposed 306,266 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration"). F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").
F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 1, 2026 18:25 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | Disposition to issuerCommon Stock | 306,266 | $16.50 | $5,053,389.00 |
DisclosureSEC source: 0001477553-26-000005 · form4-07012026_060716.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration"). F2 · shares: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 21:18 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,094 | $16.45 | $17,996.30 |
DisclosureSEC source: 0001477553-26-000004 · form4-04292026_090449.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,266 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:35 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,109 | $16.23 | $17,999.07 |
DisclosureSEC source: 0001477553-26-000002 · form4-02132026_090218.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,172 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 21:24 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,266 | $14.22 | $18,002.52 |
DisclosureSEC source: 0001477553-25-000004 · form4-10302025_091058.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,063 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 21:03 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 14,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-020751 · form4-07312025_090730.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,797 F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on July 29, 2026, the first anniversary of the grant date. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 21:03 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,263 | $14.25 | $17,997.75 |
DisclosureSEC source: 0001415889-25-020751 · form4-07312025_090730.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,762 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 22:36 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 978 | $18.41 | $18,004.98 |
DisclosureSEC source: 0001415889-25-011595 · form4-04302025_100443.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,499 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 23:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 987 | $18.24 | $18,002.88 |
DisclosureSEC source: 0001415889-25-003953 · form4-02132025_110252.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,521 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 20:16 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 543 | $33.14 | $17,995.02 |
DisclosureSEC source: 0001415889-24-025823 · form4-10312024_081027.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,534 F1 · kind: The grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a pro-rated quarterly retainer of $18,000. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:44 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 453 | $39.76 | $18,011.28 |
DisclosureSEC source: 0001415889-24-020524 · form4-08012024_080822.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,991 F1 · kind: The grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a pro-rated quarterly retainer of $18,000. Read SEC document |
| April 30, 2024 Filed May 1, 2024 23:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011923 · form4-05012024_110519.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,538 F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on April 30, 2025, the first anniversary of the grant date. Read SEC document |
| April 30, 2024 Filed May 1, 2024 23:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 634 | $28.37 | $17,986.58 |
DisclosureSEC source: 0001415889-24-011923 · form4-05012024_110519.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,538 F1 · kind: The grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a pro-rated quarterly retainer of $18,000. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 22:46 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 670 | $26.86 | $17,996.20 |
DisclosureSEC source: 0001415889-24-003604 · form4-02132024_100202.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,904 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 798 | $22.56 | $18,002.88 |
DisclosureSEC source: 0001415889-23-014740 · form4-11032023_081119.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,234 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011754 · form4-08022023_080835.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,436 F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 1, 2024, the first anniversary of the grant date. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 602 | $29.92 | $18,011.84 |
DisclosureSEC source: 0001415889-23-011754 · form4-08022023_080835.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,436 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| May 02, 2023 Filed May 3, 2023 21:40 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 615 | $29.29 | $18,013.35 |
DisclosureSEC source: 0001415889-23-007238 · form4-05032023_090527.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,834 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:31 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 602 | $29.90 | $17,999.80 |
DisclosureSEC source: 0001415889-23-002705 · form4-02162023_110217.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,219 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 21:53 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 689 | $26.13 | $18,003.57 |
DisclosureSEC source: 0001415889-22-011072 · form4-11032022_021108.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,617 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 01:36 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 606 | $29.71 | $18,004.26 |
DisclosureSEC source: 0001415889-22-008229 · form4-08032022_060820.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,928 F2 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 01:36 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008229 · form4-08032022_060820.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,322 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 1, 2023, the first anniversary of the grant date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:21 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 6,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005900 · form4-05312022_010518.xml · derivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,726 Underlying: Common Stock · 6,726 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 04, 2022 Filed May 5, 2022 21:19 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 778 | $23.15 | $18,010.70 |
DisclosureSEC source: 0001179110-22-002858 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,322 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 22:07 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 745 | $24.17 | $18,006.65 |
DisclosureSEC source: 0001179110-22-001449 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,544 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 531 | $33.89 | $17,995.59 |
DisclosureSEC source: 0001179110-21-009836 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,799 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| September 29, 2021 Filed Feb 3, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000786 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Woodland Northwest, LLC Disclosed balance after: 7,500 F1 · ownership.nature: The shares are held of record by Woodland Northwest, LLC. Read SEC document |
| September 29, 2021 Filed Feb 3, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000786 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-21-008825 · edgar.xml · derivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,850 Underlying: Common Stock · 7,500 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,500 | $6.01 | $45,075.00 |
DisclosureSEC source: 0001179110-21-008825 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:13 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 454 | $39.66 | $18,005.64 |
DisclosureSEC source: 0001179110-21-007945 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,268 F2 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:13 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007945 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,814 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 3, 2022, the first anniversary of the grant date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 10:38 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 416 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-020295 · form4.xml · derivative · entry 6 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 416 shares Expires 2028-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 10:38 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-020295 · form4.xml · derivative · entry 5 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 250 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 10:38 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001127602-21-020295 · form4.xml · derivative · entry 4 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 250 shares Expires 2027-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 10:38 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 416 | $4.70 | $1,955.20 |
DisclosureSEC source: 0001127602-21-020295 · form4.xml · nonDerivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 10:38 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 250 | $4.70 | $1,175.00 |
DisclosureSEC source: 0001127602-21-020295 · form4.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 10:38 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 250 | $4.50 | $1,125.00 |
DisclosureSEC source: 0001127602-21-020295 · form4.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 18, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005488 · edgar.xml · derivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 1,638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 12, 2021 Filed May 13, 2021 21:51 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 667 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-016683 · form4.xml · derivative · entry 4 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 667 shares Expires 2028-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. Read SEC document |
| May 12, 2021 Filed May 13, 2021 21:51 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-016683 · form4.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 250 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. Read SEC document |
| May 12, 2021 Filed May 13, 2021 21:51 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 667 | $4.70 | $3,134.90 |
DisclosureSEC source: 0001127602-21-016683 · form4.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 13, 2021 21:51 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 250 | $4.70 | $1,175.00 |
DisclosureSEC source: 0001127602-21-016683 · form4.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 14, 2021 18:44 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | PurchaseClass A Common Stock | 13,000 | $7.83 | $101,790.00 |
DisclosureSEC source: 0001775625-21-000058 · wf-form4_162101785305607.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,241 Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:32 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 471 | $38.22 | $18,001.62 |
DisclosureSEC source: 0001179110-21-004931 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,814 F1 · kind: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 14:53 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 833 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-014555 · form4.xml · derivative · entry 6 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917 Underlying: Common Stock · 833 shares Expires 2028-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option (including 10,833 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 14:53 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001127602-21-014555 · form4.xml · derivative · entry 5 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 Underlying: Common Stock · 500 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to this option (including 9,000 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 14:53 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001127602-21-014555 · form4.xml · derivative · entry 4 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 500 shares Expires 2027-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to this option (including 11,250 shares which have previously been exercised and purchased prior to the date hereof) shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 14:53 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 833 | $4.70 | $3,915.10 |
DisclosureSEC source: 0001127602-21-014555 · form4.xml · nonDerivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 14:53 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 500 | $4.70 | $2,350.00 |
DisclosureSEC source: 0001127602-21-014555 · form4.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 14:53 UTC | Accolade, Inc. ACCD · Entity 80959 | Exercise / conversionCommon Stock | 500 | $4.50 | $2,250.00 |
DisclosureSEC source: 0001127602-21-014555 · form4.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.